Advances in the Study of Common and Rare CFTR Complex Alleles Using Intestinal Organoids

被引:0
|
作者
Krasnova, Maria [1 ]
Efremova, Anna [1 ]
Mokrousova, Diana [1 ]
Bukharova, Tatiana [1 ]
Kashirskaya, Nataliya [1 ,2 ]
Kutsev, Sergey [1 ]
Kondratyeva, Elena [1 ]
Goldshtein, Dmitry [1 ]
机构
[1] Res Ctr Med Genet, Moscow 115522, Russia
[2] Moscow Reg Res & Clin Inst MONIKI, Schepkina St 61-2,1, Moscow 129110, Russia
来源
JOURNAL OF PERSONALIZED MEDICINE | 2024年 / 14卷 / 02期
关键词
complex allele; cystic fibrosis; CFTR; intestinal organoid; targeted therapy; CFTR modulators; CONDUCTANCE REGULATOR CFTR; STEM-CELLS; MUTATIONS; PHENOTYPE; MECHANISM; RESCUE;
D O I
10.3390/jpm14020129
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Complex alleles (CAs) arise when two or more nucleotide variants are present on a single allele. CAs of the CFTR gene complicate the cystic fibrosis diagnosis process, classification of pathogenic variants, and determination of the clinical picture of the disease and increase the need for additional studies to determine their pathogenicity and modulatory effect in response to targeted therapy. For several different populations around the world, characteristic CAs of the CFTR gene have been discovered, although in general the prevalence and pathogenicity of CAs have not been sufficiently studied. This review presents examples of using intestinal organoid models for assessments of the two most common and two rare CFTR CAs in individuals with cystic fibrosis in Russia.
引用
收藏
页数:13
相关论文
共 43 条
  • [41] CAN USE OF HIGH COST DRUGS FOR RARE RHEUMATIC DISEASES BE RELIABLY IDENTIFIED WITHIN ROUTINELY COLLECTED NHS DATA? RESULTS FROM A PILOT STUDY OF RITUXIMAB USE IN VASCULITIS USING DATA FROM THE NATIONAL DISEASE REGISTRATION SERVICE (NDRS) AND THE REGISTRATION OF COMPLEX RARE DISEASES - EXEMPLARS IN RHEUMATOLOGY (RECORDER) PROJECT
    Chakravorty, Mithun
    Pearce, Fiona
    Rutter, Megan
    Lanyon, Peter
    Aston, Jeanette
    Bythell, Mary
    Stevens, Sarah
    RHEUMATOLOGY, 2021, 60
  • [42] MULTICENTER STUDY TO CLARIFY THE MECHANISMS INVOLVED IN THE DEVELOPMENT OF NS5A-P32del, A RARE RAS WITH EXTREME TOLERANCE TO NS5A REPLICATION COMPLEX INHIBITORS: ANALYSES USING DIRECT AND DEEP SEQUENCING AND STRUCTURAL MODELING
    Uchida, Yoshihito
    Kouyama, Jun-Ichi
    Naiki, Kayoko
    Sugawara, Kayoko
    Nakayama, Nobuaki
    Imai, Yukinori
    Tomiya, Tomoaki
    Mochida, Satoshi
    HEPATOLOGY, 2019, 70 : 992A - 993A
  • [43] P091 Can use of high cost drugs for rare rheumatic diseases be reliably identified within routinely collected NHS data? Results from a pilot study of rituximab use in vasculitis using data from the National Disease Registration Service (NDRS) and the Registration of Complex Rare Diseases-Exemplars in Rheumatology (RECORDER) project
    Chakravorty, Mithun
    Pearce, Fiona
    Rutter, Megan
    Lanyon, Peter
    Aston, Jeanette
    Bythell, Mary
    Stevens, Sarah
    RHEUMATOLOGY, 2021, 60